COUNSEL: DO NOT ADD PARTIES. (2:17-md-02785)"> COUNSEL: DO NOT ADD PARTIES. drug patent litigation (2:17-md-02785)"> COUNSEL: DO NOT ADD PARTIES. (2:17-md-02785)"> In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation <b><font color="red">COUNSEL: DO NOT ADD PARTIES.</font></b> drug patent litigation (2:17-md-02785) COUNSEL: DO NOT ADD PARTIES.|2:17-md-02785">

Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Julphar
Farmers Insurance
Merck
AstraZeneca
Argus Health
Boehringer Ingelheim
McKinsey
Moodys

Generated: December 18, 2018

DrugPatentWatch Database Preview

Litigation Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

« Back to Dashboard

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Docket ➤ Sign Up Date Filed 2017-08-04
Court District Court, D. Kansas Date Terminated
Cause 28:1407 Multi-District Litigation Assigned To Daniel Dale Crabtree
Jury Demand Both Referred To
Parties AMBER RAINEY; CHRISTINA KOLLMEYER; EXPRESS SCRIPTS HOLDING COMPANY; EXPRESS SCRIPTS, INC.; JAMIE HERR; LINDSEY RIZZO; LISA VOGEL; OPTUMRX, INC.; PRIME THERAPEUTICS, LLC; ROBERT MONTOYA; TRACI BRANNON; UNITEDHEALTH GROUP, INC.; VALERIE MOORE; WILLIAM DELPRINCIPE
Patents 7,449,012; 7,794,432
Attorneys Arthur R. Miller; Bradley Joseph Schlozman; Craig L. Briskin; Cristina R. Delise; Dennis Lienhardt , Jr.; E. Powell Miller; Elizabeth C. Pritzker; Jennifer Fountain Connolly; Jonathan K. Levine; Joseph G. Sauder; Mitchell L. Herren; Paul J. Geller; Reagan E. Bradford; Rex A. Sharp; Ryan C. Hudson; Scott B. Goodger; Sharon S. Almonrode; Steve W. Berman; Steven N. Williams; W. Mark Lanier; William D. Beil
Firms Cotchett Pitre and McCarthy; German May PC; Hagens Berman Sobol Shapiro LLP Seattle; Hinkle Law Firm LLC East Wichita Office; McCune Wright Arevalo, LLP; Mehri & Skalet PLLC; Pritzker Levine LLP; Rex a Sharp PA; Robins Geller Rudman & Dowd LLP - FL; The Lanier Law Firm; The Lanier Law Firm PC; The Lanier Law Firm, PC; The Miller Law Firm; Wexler Wallace LLP
Link to Docket External link to docket
Small Molecule Drugs cited in In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES.
The small molecule drug covered by the patents cited in this case is ➤ Sign Up .

Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-08-20 896 Order on Motion to Dismiss Meridian—sued Teva for infringing U.S. Patent No. 7,449,012 (“the Teva Litigation”). In November 2010…Defendants did so by adding several more patents to the already-patented EpiPen to prevent the launch of competing…2009 that Mylan was adding another patent to the already-patented EpiPen device that “will also put in… ’432 patent. Later, King and Meridian dropped their claims based on infringing the ’012 patent, leaving…that Intelliject’s EAI infringed the ’432 patent—a patent that Meridian secured more than a year after External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Dow
Teva
Merck
Daiichi Sankyo
Citi
Colorcon
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.